Alembic Ltd.
| BSE: 506235 | Sector: Health care |
| NSE: ALEMBICLTD | ISIN Code: INE426A01027 |
| BSE 00:00 | 23 Sep | 120.50 |
4.55 (3.92%) |
OPEN
117.90 |
HIGH
124.20 |
LOW
116.00 |
| NSE 00:00 | 23 Sep | 120.50 |
4.55 (3.92%) |
OPEN
116.85 |
HIGH
125.00 |
LOW
116.00 |
| OPEN | 117.90 |
| PREVIOUS CLOSE | 115.95 |
| VOLUME | 255895 |
| 52-Week high | 143.30 |
| 52-Week low | 83.00 |
| P/E | 204.24 |
| Mkt Cap.(Rs cr) | 3,094 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Alembic Ltd. (ALEMBICLTD) - Market Capital
Market Cap
| COMPANY | LATEST(Rs) | CHG(%) | 52 Wk High | 52 Wk Low | MKT-CAP (RS CR) |
| Sun Pharma.Inds. | 769.75 | 0.00 | 804.40 | 452.60 | 184686.11 |
| Divi's Lab. | 5212.85 | 1.29 | 5269.00 | 2986.70 | 138375.10 |
| Dr Reddy's Labs | 4796.00 | -1.07 | 5613.65 | 4135.90 | 79805.44 |
| Cipla | 968.05 | 0.35 | 997.20 | 706.45 | 78087.75 |
| Apollo Hospitals | 5094.35 | 3.96 | 5135.35 | 1762.40 | 73246.56 |
| Piramal Enterp. | 2778.95 | 5.21 | 2856.80 | 1178.85 | 66319.64 |
| Gland Pharma | 3910.10 | 0.98 | 4350.00 | 1701.00 | 64203.84 |
| Cadila Health. | 566.90 | 1.02 | 673.70 | 373.95 | 58033.55 |
| Torrent Pharma. | 3102.20 | 0.48 | 3226.05 | 2311.30 | 52495.43 |
| Alkem Lab | 3964.20 | 1.95 | 3979.50 | 2544.25 | 47392.01 |
| Abbott India | 21588.45 | 0.55 | 21850.00 | 13970.10 | 45875.46 |
| Biocon | 367.80 | 0.07 | 487.70 | 327.75 | 44158.07 |
| Aurobindo Pharma | 733.60 | 0.32 | 1063.75 | 660.10 | 42981.62 |
| Lupin | 940.40 | 0.07 | 1267.50 | 856.00 | 42698.86 |
| Max Healthcare | 371.30 | 0.15 | 472.60 | 102.50 | 35865.72 |
| Dr Lal Pathlabs | 4040.15 | 1.25 | 4243.00 | 1762.40 | 33670.61 |
| Laurus Labs | 621.95 | 0.10 | 723.55 | 249.29 | 33373.84 |
| Ipca Labs. | 2475.55 | 1.89 | 2767.10 | 1786.05 | 31402.35 |
| Pfizer | 5821.30 | 0.54 | 6164.80 | 4200.00 | 26632.45 |
| Syngene Intl. | 657.60 | -0.70 | 699.95 | 490.35 | 26356.61 |
Quick Links for Alembic:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
